共 94 条
[1]
Lo C-M(2002)Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164-1171
[2]
Ngan H(2002)Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734-1739
[3]
Tso W-K(2010)Which transarterial therapy is best for hepatocellular carcinoma?—the evidence to date J Hepatol 53 588-408
[4]
Llovet JM(2015)Intermediate hepatocellular carcinoma: the role of transarterial therapy Hepatic Oncol 2 399-800
[5]
Real MI(2016)TAE for HCC: when the old way is better than the new ones!!! Cardiovasc Interv Radiol 39 799-936
[6]
Montaña X(2005)Angiogenesis in life, disease and medicine Nature 438 932-11
[7]
Tsochatzis E(2013)Chemoembolization of hepatocellular carcinoma Semin Interv Radiol 30 3-526
[8]
Meyer T(2010)Arterial patency after repeated hepatic artery bland particle embolization J Vasc Interv Radiol 21 522-292
[9]
Marelli L(2016)Impact of different embolic agents for transarterial chemoembolization (TACE) procedures on systemic vascular endothelial growth factor (VEGF) levels J Clin Transl Hepatol 4 288-441
[10]
Burroughs AK(2015)Temporary arterial embolization of liver parenchyma with degradable starch microspheres (EmboCept( Cardiovasc Interv Radiol 38 435-164